ONGOING CLINICAL TRIALS
ZymoGenetics is conducting the following clinical trials.
For more information about a study, click on one of the links below.
|
Product Candidate |
Medical area & Stage of development |
| RECOTHROM® |
Indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques is ineffective or impractical - Marketed |
| IL-21 |
For treatment of metastatic melanoma, renal cell carcinoma and lymphoma - Phase 1/2 |
| PEG-interferon lambda |
For treatment of hepatitis C - Phase 1 |
| |
|
|
Back to top
